253 related articles for article (PubMed ID: 25651758)
21. That which does not kill us makes us stronger--does Nietzsche's quote apply to islets? A re-evaluation of the passenger leukocyte theory, free radicals, and glucose toxicity in islet cell transplantation.
Wright JR; Xu BY
Med Hypotheses; 2014 Jul; 83(1):92-8. PubMed ID: 24767938
[TBL] [Abstract][Full Text] [Related]
22. Impact of Oxygen on Pancreatic Islet Survival.
Komatsu H; Kandeel F; Mullen Y
Pancreas; 2018; 47(5):533-543. PubMed ID: 29621044
[TBL] [Abstract][Full Text] [Related]
23. Quality control for clinical islet transplantation: organ procurement and preservation, the islet processing facility, isolation, and potency tests.
Yamamoto T; Horiguchi A; Ito M; Nagata H; Ichii H; Ricordi C; Miyakawa S
J Hepatobiliary Pancreat Surg; 2009; 16(2):131-6. PubMed ID: 19242650
[TBL] [Abstract][Full Text] [Related]
24. Islet engraftment and revascularization in clinical and experimental transplantation.
Molnár C; Essand M; Wennberg L; Berne C; Larsson E; Tufveson G; Korsgren O
Cell Transplant; 2013; 22(2):243-51. PubMed ID: 22584061
[TBL] [Abstract][Full Text] [Related]
25. Roles of Toll-like receptors in allogeneic islet transplantation.
Ro H; Hong J; Kim BS; Lee EW; Kim MG; Han KH; Yeom HJ; Lee EM; Jeong JC; Oh KH; Ahn C; Yang J
Transplantation; 2012 Nov; 94(10):1005-12. PubMed ID: 23169223
[TBL] [Abstract][Full Text] [Related]
26. Bilirubin Improves the Quality and Function of Hypothermic Preserved Islets by Its Antioxidative and Anti-inflammatory Effect.
Yao Q; Jiang X; Huang ZW; Lan QH; Wang LF; Chen R; Li XZ; Kou L; Xu HL; Zhao YZ
Transplantation; 2019 Dec; 103(12):2486-2496. PubMed ID: 31365475
[TBL] [Abstract][Full Text] [Related]
27. A new mouse model for intraportal islet transplantation with limited hepatic lobe as a graft site.
Yonekawa Y; Okitsu T; Wake K; Iwanaga Y; Noguchi H; Nagata H; Liu X; Kobayashi N; Matsumoto S
Transplantation; 2006 Sep; 82(5):712-5. PubMed ID: 16969298
[TBL] [Abstract][Full Text] [Related]
28. The choice of anatomical site for islet transplantation.
van der Windt DJ; Echeverri GJ; Ijzermans JN; Cooper DK
Cell Transplant; 2008; 17(9):1005-14. PubMed ID: 19177837
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal.
Jalili RB; Moeen Rezakhanlou A; Hosseini-Tabatabaei A; Ao Z; Warnock GL; Ghahary A
J Cell Physiol; 2011 Jul; 226(7):1813-9. PubMed ID: 21506112
[TBL] [Abstract][Full Text] [Related]
30. The pancreatic islet as a signaling hub.
Barker CJ; Leibiger IB; Berggren PO
Adv Biol Regul; 2013 Jan; 53(1):156-63. PubMed ID: 23073565
[TBL] [Abstract][Full Text] [Related]
31. Intraportal islet transplantation: the impact of the liver microenvironment.
Delaune V; Berney T; Lacotte S; Toso C
Transpl Int; 2017 Mar; 30(3):227-238. PubMed ID: 28109023
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survival.
Akamaru Y; Ito T; Uchikoshi F; Maeda A; Tori M; Kiyomoto T; Komoda H; Miao G; Matsuda H
Transpl Immunol; 2003; 11(1):91-100. PubMed ID: 12727480
[TBL] [Abstract][Full Text] [Related]
33. Overcoming the challenges now limiting islet transplantation: a sequential, integrated approach.
Pileggi A; Cobianchi L; Inverardi L; Ricordi C
Ann N Y Acad Sci; 2006 Oct; 1079():383-98. PubMed ID: 17130583
[TBL] [Abstract][Full Text] [Related]
34. Hypoxic resistance of hypodermically transplanted pancreatic islets by using cell-absorbable antioxidant Tat-metallothionein.
Jung HS; Lim KS; Kim MJ; Hwang YH; Yoo C; Lee YK; Kim YH; Lee DY
J Control Release; 2013 Dec; 172(3):1092-101. PubMed ID: 24103814
[TBL] [Abstract][Full Text] [Related]
35. Biological and biomaterial approaches for improved islet transplantation.
Narang AS; Mahato RI
Pharmacol Rev; 2006 Jun; 58(2):194-243. PubMed ID: 16714486
[TBL] [Abstract][Full Text] [Related]
36. Revascularization of transplanted pancreatic islets following culture with stimulators of angiogenesis.
Olsson R; Maxhuni A; Carlsson PO
Transplantation; 2006 Aug; 82(3):340-7. PubMed ID: 16906031
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation.
Lopez-Talavera JC; Garcia-Ocaña A; Sipula I; Takane KK; Cozar-Castellano I; Stewart AF
Endocrinology; 2004 Feb; 145(2):467-74. PubMed ID: 14551233
[TBL] [Abstract][Full Text] [Related]
38. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
39. Effects of glucagon-like peptide 1 analogue on the early phase of revascularization of transplanted pancreatic islets in a subcutaneous site.
Nishimura R; Ushiyama A; Sekiguchi S; Fujimori K; Ohuchi N; Satomi S; Goto M
Transplant Proc; 2013 Jun; 45(5):1892-4. PubMed ID: 23769065
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol fails to improve marginal mass engraftment of transplanted islets of Langerhans in mice.
McCall MD; Pawlick R; Shapiro AM
Islets; 2011; 3(5):241-5. PubMed ID: 21904116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
